Jefferies Group initiated coverage on shares of AptarGroup Inc. (NYSE:ATR) in a research report report published on Thursday morning. The brokerage issued a hold rating and a $83.00 price target on the stock.

Other research analysts also recently issued research reports about the company. BMO Capital Markets reaffirmed a hold rating on shares of AptarGroup in a research note on Friday, September 9th. Robert W. Baird boosted their price target on AptarGroup from $80.00 to $84.00 and gave the company a neutral rating in a research note on Friday, September 9th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and three have given a buy rating to the company’s stock. The company presently has an average rating of Hold and an average price target of $77.75.

Shares of AptarGroup (NYSE:ATR) traded up 0.07% on Thursday, hitting $75.64. 27,555 shares of the stock traded hands. AptarGroup has a 1-year low of $66.33 and a 1-year high of $81.50. The stock has a market cap of $4.76 billion, a PE ratio of 24.56 and a beta of 0.87. The stock has a 50 day moving average of $77.76 and a 200-day moving average of $77.71.

AptarGroup (NYSE:ATR) last posted its quarterly earnings results on Thursday, July 28th. The company reported $0.91 EPS for the quarter, beating the Zacks’ consensus estimate of $0.90 by $0.01. The business earned $620 million during the quarter, compared to the consensus estimate of $621.52 million. AptarGroup had a return on equity of 16.67% and a net margin of 8.54%. AptarGroup’s revenue for the quarter was up 4.3% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.82 earnings per share. On average, equities research analysts expect that AptarGroup will post $3.18 EPS for the current year.

In related news, CFO Robert Kuhn sold 3,000 shares of the company’s stock in a transaction that occurred on Friday, August 26th. The stock was sold at an average price of $78.59, for a total value of $235,770.00. Following the sale, the chief financial officer now directly owns 15,050 shares in the company, valued at $1,182,779.50. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Salim Haffar sold 50,333 shares of the company’s stock in a transaction that occurred on Friday, September 2nd. The shares were sold at an average price of $78.74, for a total value of $3,963,220.42. Following the completion of the sale, the insider now owns 23,149 shares in the company, valued at $1,822,752.26. The disclosure for this sale can be found here. Insiders own 5.50% of the company’s stock.

A number of hedge funds have recently made changes to their positions in the stock. Royal Bank of Canada boosted its stake in shares of AptarGroup by 6.4% in the first quarter. Royal Bank of Canada now owns 169,158 shares of the company’s stock valued at $13,263,000 after buying an additional 10,226 shares during the last quarter. Arizona State Retirement System boosted its stake in shares of AptarGroup by 3.8% in the first quarter. Arizona State Retirement System now owns 32,504 shares of the company’s stock valued at $2,549,000 after buying an additional 1,200 shares during the last quarter. Magnetar Financial LLC bought a new stake in shares of AptarGroup during the first quarter valued at approximately $232,000. Metropolitan Life Insurance Co. NY boosted its stake in shares of AptarGroup by 3.5% in the first quarter. Metropolitan Life Insurance Co. NY now owns 57,478 shares of the company’s stock valued at $4,507,000 after buying an additional 1,948 shares during the last quarter. Finally, Springbok Capital Management LLC bought a new stake in shares of AptarGroup during the first quarter valued at approximately $243,000. Institutional investors and hedge funds own 88.33% of the company’s stock.

AptarGroup Company Profile

AptarGroup, Inc is a provider of a range of packaging, dispensing and sealing solutions, primarily for the beauty, personal care, home care, prescription drug, consumer healthcare, injectables, food and beverage markets. The Company has manufacturing facilities located in North America, Europe, Asia and South America.

5 Day Chart for NYSE:ATR

Receive News & Stock Ratings for AptarGroup Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AptarGroup Inc. and related stocks with our FREE daily email newsletter.